12th May 2023 17:04
Arix Bioscience PLC - London-based transatlantic venture capital company focused on investing in biotechnology companies that are advancing in life science - Reports its estimated net asset value stood at 177.0 pence per share at April 30.
Arix adds that that its NAV stood at GBP58.1 million for its listed portfolio, GBP63.5 million for its unlisted portfolio, GBP104.2 million in cash, and GBP3.0 million for other interests, which accumulated at GBP228.8 million for total NAV.
Current share price: 106.05 pence
12-month change: down 9.4%
By Will Neill, Alliance News reporter
Comments and questions to [email protected]
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Related Shares:
ARIX.L